Cargando…

Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?

Laparoscopic sleeve gastrectomy (LSG) has reached wide popularity during the last 15 years, due to the limited morbidity and mortality rates, and the very good weight loss results and effects on comorbid conditions. However, there are concerns regarding the effects of LSG on gastroesophageal reflux...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebecchi, Fabrizio, Allaix, Marco E, Patti, Marco G, Schlottmann, Francisco, Morino, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385393/
https://www.ncbi.nlm.nih.gov/pubmed/28428706
http://dx.doi.org/10.3748/wjg.v23.i13.2269
_version_ 1782520591564144640
author Rebecchi, Fabrizio
Allaix, Marco E
Patti, Marco G
Schlottmann, Francisco
Morino, Mario
author_facet Rebecchi, Fabrizio
Allaix, Marco E
Patti, Marco G
Schlottmann, Francisco
Morino, Mario
author_sort Rebecchi, Fabrizio
collection PubMed
description Laparoscopic sleeve gastrectomy (LSG) has reached wide popularity during the last 15 years, due to the limited morbidity and mortality rates, and the very good weight loss results and effects on comorbid conditions. However, there are concerns regarding the effects of LSG on gastroesophageal reflux disease (GERD). The interpretation of the current evidence is challenged by the fact that the LSG technique is not standardized, and most studies investigate the presence of GERD by assessing symptoms and the use of acid reducing medications only. A few studies objectively investigated gastroesophageal function and the reflux profile by esophageal manometry and 24-h pH monitoring, reporting postoperative normalization of esophageal acid exposure in up to 85% of patients with preoperative GERD, and occurrence of de novo GERD in about 5% of cases. There is increasing evidence showing the key role of the surgical technique on the incidence of postoperative GERD. Main technical issues are a relative narrowing of the mid portion of the gastric sleeve, a redundant upper part of the sleeve (both depending on the angle under which the sleeve is stapled), and the presence of a hiatal hernia. Concomitant hiatal hernia repair is recommended. To date, either medical therapy with proton pump inhibitors or conversion of LSG to laparoscopic Roux-en-Y gastric bypass are the available options for the management of GERD after LSG. Recently, new minimally invasive approaches have been proposed in patients with GERD and hypotensive LES: the LINX(®) Reflux Management System procedure and the Stretta(®) procedure. Large studies are needed to assess the safety and long-term efficacy of these new approaches. In conclusion, the recent publication of pH monitoring data and the new insights in the association between sleeve morphology and GERD control have led to a wider acceptance of LSG as bariatric procedure also in obese patients with GERD, as recently stated in the 5(th) International Consensus Conference on sleeve gastrectomy.
format Online
Article
Text
id pubmed-5385393
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-53853932017-04-20 Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve? Rebecchi, Fabrizio Allaix, Marco E Patti, Marco G Schlottmann, Francisco Morino, Mario World J Gastroenterol Editorial Laparoscopic sleeve gastrectomy (LSG) has reached wide popularity during the last 15 years, due to the limited morbidity and mortality rates, and the very good weight loss results and effects on comorbid conditions. However, there are concerns regarding the effects of LSG on gastroesophageal reflux disease (GERD). The interpretation of the current evidence is challenged by the fact that the LSG technique is not standardized, and most studies investigate the presence of GERD by assessing symptoms and the use of acid reducing medications only. A few studies objectively investigated gastroesophageal function and the reflux profile by esophageal manometry and 24-h pH monitoring, reporting postoperative normalization of esophageal acid exposure in up to 85% of patients with preoperative GERD, and occurrence of de novo GERD in about 5% of cases. There is increasing evidence showing the key role of the surgical technique on the incidence of postoperative GERD. Main technical issues are a relative narrowing of the mid portion of the gastric sleeve, a redundant upper part of the sleeve (both depending on the angle under which the sleeve is stapled), and the presence of a hiatal hernia. Concomitant hiatal hernia repair is recommended. To date, either medical therapy with proton pump inhibitors or conversion of LSG to laparoscopic Roux-en-Y gastric bypass are the available options for the management of GERD after LSG. Recently, new minimally invasive approaches have been proposed in patients with GERD and hypotensive LES: the LINX(®) Reflux Management System procedure and the Stretta(®) procedure. Large studies are needed to assess the safety and long-term efficacy of these new approaches. In conclusion, the recent publication of pH monitoring data and the new insights in the association between sleeve morphology and GERD control have led to a wider acceptance of LSG as bariatric procedure also in obese patients with GERD, as recently stated in the 5(th) International Consensus Conference on sleeve gastrectomy. Baishideng Publishing Group Inc 2017-04-07 2017-04-07 /pmc/articles/PMC5385393/ /pubmed/28428706 http://dx.doi.org/10.3748/wjg.v23.i13.2269 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Editorial
Rebecchi, Fabrizio
Allaix, Marco E
Patti, Marco G
Schlottmann, Francisco
Morino, Mario
Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?
title Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?
title_full Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?
title_fullStr Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?
title_full_unstemmed Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?
title_short Gastroesophageal reflux disease and morbid obesity: To sleeve or not to sleeve?
title_sort gastroesophageal reflux disease and morbid obesity: to sleeve or not to sleeve?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385393/
https://www.ncbi.nlm.nih.gov/pubmed/28428706
http://dx.doi.org/10.3748/wjg.v23.i13.2269
work_keys_str_mv AT rebecchifabrizio gastroesophagealrefluxdiseaseandmorbidobesitytosleeveornottosleeve
AT allaixmarcoe gastroesophagealrefluxdiseaseandmorbidobesitytosleeveornottosleeve
AT pattimarcog gastroesophagealrefluxdiseaseandmorbidobesitytosleeveornottosleeve
AT schlottmannfrancisco gastroesophagealrefluxdiseaseandmorbidobesitytosleeveornottosleeve
AT morinomario gastroesophagealrefluxdiseaseandmorbidobesitytosleeveornottosleeve